Cargando…
Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is currently one of the most frequently diagnosed cancers. Our aim was to evaluate transparency and selective reporting in interventional trials studying CRC. METHODS: First, we assessed indicators of transparency with completeness of reporting, according to the C...
Autores principales: | Pellat, Anna, Boutron, Isabelle, Ravaud, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925077/ https://www.ncbi.nlm.nih.gov/pubmed/35291962 http://dx.doi.org/10.1186/s12885-022-09334-5 |
Ejemplares similares
-
Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020
por: Pellat, Anna, et al.
Publicado: (2022) -
Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years
por: Pellat, Anna, et al.
Publicado: (2022) -
Transparency and reporting characteristics of COVID-19 randomized controlled trials
por: Kapp, Philipp, et al.
Publicado: (2022) -
Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment
por: Pellat, Anna, et al.
Publicado: (2022) -
Designs of trials assessing interventions to improve the peer review process: a vignette-based survey
por: Heim, Amytis, et al.
Publicado: (2018)